Outcomes
| Classical group (n=51) | Molecular group (n=43) | p value | |
|---|---|---|---|
| Endometrial biopsy, n (%) | 0.317 | ||
| No malignancy | 44 (88) | 36 (83,9) | |
| Endometrial cancer | 1 (2) | 3 (7,14) | |
| Inadecuate | 5 (10) | 3 (7) | |
| Endometrium by US >4 mm, n (%) | 22 (43) | 26 (61.9) | 0.071 |
| Final Outcome | 0,143 | ||
| Discharged | 29 (59) | 29 (71) | |
| Hysteroscopy | 19 (39) | 9 (22) | |
| Cancer protocol | 1 (2) | 3 (7) | |